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An Analysis on Investment into Research and Development and Its Influence on
Profitability in the Medical Device Sector of the Economy
Abstract
The purpose of this paper is to analyze whether or not investing more funds into research and
development will lead to higher profitability, and the analysis will be done by examining the
musculoskeletal division of the medical device industry. My research will tie in with production function
theory as well as Schumpeter’s theory of creative destruction. This paper will also use past research to
show what has been done to evaluate the positive relationship between research and development and
risk and how this could alter profitability. Through theory and past research an appropriate testable
hypothesis will be developed. In order to test the hypothesis, data will be drawn and used in regression
analysis as well as descriptive statistics to verify a significant relationship. In order to perform regression
analysis an empirical model will be made which will show the dependent variable and how it will be tested
against an independent variable as well as control variables. A discussion of the results will then occur as
well as mention of future research.
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An Analysis on Investment into
Research and Development and Its
Influence on Profitability in the Medical
Device Sector of the Economy
Jake Nord
I. Introduction
“Fundamental to capitalistic growth is innovation.” This
quote is from the survey article entitled “Contemporary
Capitalism.”(Lazonick, 2008) Innovation is the process that
generates goods and services that are of better quality and
lower prices than their predecessors. Therefore, if a firm
explores innovation, then they will inevitably lead themselves to
an efficient allocation of society’s resources and growth within
the firm will occur. Innovation does not only improve a firm’s
profitability but also the quality of life for all consumers in the
economy. There is no greater need for innovation than in the
medical sector of the economy. With an aging population, and
an estimated life expectancy of now 78, consumers in America
are constantly demanding new hip prostheses, shoulder
fracture components, and spinal implants. The need for
innovation and the diverse investment strategies into research
and development in the medical device sector of the economy
should allow for the medical device sector to provide a good
focus for this paper’s research analysis.

to Kafouros (2005) a high investment into research and
development should have a significantly positive relationship
with productivity. A Cobb-Douglass production function as well
as Schumpeterian theory also suggests a relationship between
productivity and profitability. Finally, past research will show
how risk in investing into research and development can affect
a firm’s profitability.

The purpose of this paper is to analyze whether or not investing
more funds into research and development will lead to higher
profitability, and the analysis will be done by examining the
musculoskeletal division of the medical device industry. My
research will tie in with production function theory as well as
Schumpeter’s theory of creative destruction. This paper will
also use past research to show what has been done to evaluate
the positive relationship between research and development
and risk and how this could alter profitability. Through theory
and past research an appropriate testable hypothesis will be
developed. In order to test the hypothesis, data will be drawn
and used in regression analysis as well as descriptive statistics
to verify a significant relationship. In order to perform regression
analysis an empirical model will be made which will show
the dependent variable and how it will be tested against an
independent variable as well as control variables. A discussion
of the results will then occur as well as mention of future
research.

The research design used by Kafouros (2005) focused on the
Cobb-Douglass production function in its growth rate form.
The model contains the standard factors of capital and labor,
but also includes the factor of knowledge capital. The purpose
for including the factor of knowledge capital is to capture
the increases in productivity that come from an increase in
technology.

II. Theory
Theoretically, expenditure on research and development should
have a significantly positive relationship with the profitability of
the firm. As explained by Ikoma (2006), “Even if the production
yield gradually decreases with more innovation, simplifying
production processes can have a significant impact on profits.”
Ikoma’s idea can be shown through past research. According

Past research has been done in the UK examining 170
firms showing that an increase in research and development
expenditure will increase the firm’s productivity, Kafouros
(2005). The empirical findings show that there is a positive and
significant impact that research and development expenditure
has on productivity. There seems to be a higher rate of return
on research and development expenditures for sectors that
are the net users of innovation. In other words, for sectors of
the economy that focus on innovation, their expenditure on
research and development will have a more significant impact
on their productivity.

All of the 170 firms were quoted on the UK stock market. The
firms chosen for the research come from the manufacturing
sector of the UK economy, and information on all firms
were found, however some firms were reported as having
no investment into research and development and were
disregarded. Furthermore, the 170 firms are segregated
into two groups; innovating and non-innovating for a deeper
evaluation of the data. (Kafouros, 2005)
The paper uses what it calls “R&D intensity” which is the
average of R&D expenditure over sales for the year as its main
factor in determining profitability. The average R&D intensity
for all of the UK manufacturing is 2.1%. In order to calculate
productivity, data were collected on employment, capital and
output for each firm. Employment was calculated as the firm’s
number of employees, capital was measured using total fixed
gross assets, and finally total sales were used to measure
output. Sales and capital were both divided by employment in
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Figure 1:

order to get per capita values. (Kafouros 2005)
The regression analysis used in this article was ordinary least
squares. The article runs three regressions. The dependent
variable of each model is productivity growth. The first model
included only the capital to labor ratio. The second added R&D
intensity to the mix. Finally the labor term was added for the
third regression in order to check for constant returns to scale.
The same estimates are then repeated in the article with the 10
sector dummy variables in order to check for a consistency over
all sectors.
The results show that R&D intensity is significant at the .10
level. The gross rate of return, accounting for constant returns
to scale and labor, is .27. In other words, for every addition
pound spent on research and development yielded output
would increase by £1.27 holding all other things constant. The
results found by Kafouros are similar to results found in Japan,
the US, and France which were done in other similar research
papers. When the sample is split, there is a higher return for
innovating firms than non-innovating firms. This shows that
being an innovator is an important factor when considering
investment into research and development. However, once
dummy variables were introduced the variable R&D intensity
became insignificant. The dummy variables include time
differences and industry differences. The results here show
that there is an important role for different sector conditions
in allowing for innovation and advancement in productivity.
(Kafouros 2005)
Kafouros (2005) shows that there is a significant and positive
correlation between research and development expenditure
and productivity. The findings here are extremely crucial
because if we can show that if the profitability of a firm rises
along with productivity of a firm then theoretically research and
development expenditure should have a significant and positive
relationship with the profitability of the firm. In order to show
this relationship I will use Cobb-Douglass Production as well as
Schumpeterian theory.
As shown by Howitt (2008), the Cobb-Douglass production
function shows that advancement in technology leads to a
higher growth in output. The Cobb-Douglass production
function is an extension of the typical production function that
states that q = F (K,L). Here, the output of a firm is dependent
on a function of capital and labor. The Cobb-Douglass
production function takes this concept a little bit further and
states F(K,L) = AKαLβ. The important thing to notice about this
equation is the addition of the “A” variable. “A” is a constant
which represents technology or productivity. According to the
Cobb-Douglass production function “The larger the value of A,
more can be produced for a given level of K and L. (Pindyke,
2009)” By applying this to my research paper we can see
that theoretically a larger investment into R&D should result
in a greater change in “A”, which would cause the company
to become more efficient in its production. Technological
improvement is shown illustratively in Figure 1.

The Cobb-Douglass production function shows that if there is
advancement in technology, then there will be output growth.
The next step is to show the relationship between output growth
and profitability growth. If there is an increase in the productivity
of a firm, this means that the firm can generate more output
for each input, and as shown in figure 1, the curve of the
production function will rise. Therefore, there will be a fall in per
unit cost for the firm and profits will rise. If this occurs then the
firm may become more profitable. Not only could investment in
R&D boost production, but it could also create new products.
The new products could bring in new profits by themselves,
thus leading to a growth in profitability.
Along the lines of new products comes Schumpeterian theory.
This theory was developed by Joseph Schumpeter in 1942.
Schumpeter argues that “in dealing with capitalism we are
dealing with an evolutionary process.” He goes on to state
that the “main driving force of capitalism is the creation of new
goods and new methods of production.( Heertje, 2008)” The
theory centers around the idea that when innovation takes place
new products are made that cause older products to become
obsolete. He calls this process “creative destruction” because
the creation of a new product destroys the market for an older
product. Schumpeter argues that in order for firms to survive in
an industry they must compete for creating new products. Firms
do this by investing into research and development. In other
words in order for an economy to grow faster the economy
must invest more capital and resources into research and
development. Schumpeter goes on to argue that the process
of creative destruction takes time. Investment into research
and development may not have an influence in the economy
for a number of years. Interestingly Schumpeter argues that
price competition is not the only component of market behavior.
Rather, firms compete for producing new advanced products.
Therefore, by investing more into research and development a
firm has a higher probability of creating that new product, which
will give them higher returns, and therefore higher profitability.
As shown by past research done by Kaforous (2005) as well
as the Cobb-Douglass production function and Schumpeterian
theory, as a firm invests more funds into research and
development the firm should experience higher profitability.
Theoretically it is true that as firms invest more into research
and development they will experience higher profitability.
However, investing into research and development is
investing into an unforeseeable future. The risk is that there
is a possibility of the new product not performing well, not
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being desired, or not outperforming other products in the
market. Therefore, as a firm invests more into research and
development they are taking a gamble. The gamble will
theoretically, on average, generate higher profits. However,
gambling on R&D will also likely generate greater variability in
profits compared to firms that do not take significant gambles
on R&D.
Machina and Rothschild (2008) state that, “The phenomenon
of risk is one of the key determining factors in the formation of
investment decisions.” Furthermore, the article states that there
can be two types of investors in an economy, a risk adverse
person and a risk lover. In relation to this paper, companies that
invest little into research and development may be more risk
adverse than those that invest more funds into research and
development. The incentive for a risk loving investor should
be that the possible gains of his investment should be more
than the possible losses. Therefore, even with the possibility
of the investment into research and development going sour,
the possible gains should outweigh the possible losses. As
firms invest more into research and development we should
see a higher volatility of returns, however the overall correlation
taking into account this volatility, should still be positive between
investment into research and development and profitability.
This leads me to state my formal hypotheses:
Hypothesis I
As more funds are spent on research and development a firm’s
profitability will increase leading to a higher rate of return on the
firm’s stock price.
Hypothesis II
As more funds are spent on research and development a firm’s
profitability will become more volatile causing a firm’s rate of
return on their stock price to fluctuate more over time.
III. Data and Empirical Model
The data for my empirical model will come from the
musculoskeletal division of the medical device industry of the
economy. The companies have been gathered from the Cowen
and Company Publically Traded Medical Technology Company
Database. The data gathered for each company come from
Yahoo! Finance and MSN Money. It will be necessary to
manipulate the data, and use variables to control for differences
between the companies. There are 16 companies in the
analysis. A list of these companies can be seen in appendix 1.
This paper will use ordinary least squares (OLS) regression
analysis as well as descriptive statistics to study the relationship
between investment into research and development and
profitability.
The reason for using the musculoskeletal division of the medical
device sector stems from past research done by Kafouros
(2005). The article shows that the sectors of the economy that
experience the greatest growth in productivity from research
and development expenditure are those companies that are
the net users of innovation. In order to derive the best possible
results it is necessary to use an industry that focuses on
innovation. Medicine is one of those industries. As Americans
are living longer, the older generation is continuously looking
for new orthopedic devices. The advancing demand causes
healthcare to be a hub for technological advancement.

In order to measure the profitability of each firm this paper uses
each firms’ rate of return on their stock price over the recent
recession, which started in December 2007 and ended in June
2009. Since many of the companies’ data do not date back
to before the most recent economic expansion this analysis
is restricted to only focusing on the most recent economic
recession, with no expansionary period included. The reason
for using stock prices is that the stock price of a firm should
reflect investor’s perception of the present value of future net
earnings for that firm.
In order to measure investment into research and development
it is necessary to extrapolate the data from the financial sheets
of each company. In order to control for the differing sizes in
each company, investment into research and development
is taken as a percentage of revenue. Since research and
development expenditures usually do not affect the market for
1.5 to 3 years it will be necessary to view the investment into
research and development from 2005 to 2007. Other controls
are necessary for the OLS regression. A summary of all of the
variables for this paper’s analysis is listed in Table 1.
Equation for my analysis: Rate of return = β1 + β2(R&D/
Revenue) + β3(Growth) + β4(Free Cash Flow) + β5(Market
Share) + β6(Size) + β7(External Financial Dependence) + e
The control variables seen in the table come from (Salamanca
2010). In his article he describes how a number of variables
could affect a firm’s decision on how much to invest into
research and development. His analysis will give the correct set
of tools to control for various factors that could affect investment
into research and development.
Firm growth should have a positive relationship with profitability.
R&D spending facilitates the success of the firm in the product
market, and as a result, R&D spending leads to a higher rate of
growth. Therefore, if a firm has been successful in the market in
previous years, then they will most likely have better success in
their research and development expenditures in the future. This
is needed to control for in explaining why some firms may invest
more into research and development than others.
Free cash flow is a measurement of all of the available funds
in excess of funds needed to pay for all NPV projects. This
statistic is taken off of each company’s financial statements.
According to the article free cash flow should have a negative
impact on a firm’s profitability because a firm with excess funds
may be persuaded to invest into riskier endeavors.
Market share is the percentage of sales a firm has of the
total sales in their market. For this dataset each company’s
revenues are added up and that is the market base. The market
share for each company is calculated as the percentage of
each company’s revenue of the market base. According to the
article market share should have a positive relationship with
profitability. A firm with higher market share will tend to innovate
more, leading to more profitability. Also a company with a
higher market share may be more widely known and have their
products tested by the public more often than other firm’s due to
reputation.
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The size of a firm is a measurement of how many employees
the firm has. According to the article the size of a firm is
positively related to firm profitability. A larger firm can take
advantage of economies of scale as well as easier access to
capital markets and R&D cost spreading.
External financial dependence captures the proportion of
a firm’s investments that cannot be financed by internal
resources. According to the article external financial
dependence is a “handicap” that is negatively assessed by
the market when firms undertake R&D projects. What the
article means by a “handicap” is that the firm may not be able
to explore all possible R&D projects because they are being
funded by outside sources. Therefore, firms with more external
financial dependence may be at a disadvantage.

by evaluating the statistical differences in means of the rate of
returns for the two groups as well as evaluating the statistical
difference in each groups’ standard deviation of their rate of
return.
In order to perform descriptive statistics the data were split into
two groups, which are a low investment into R&D group and
a high investment into R&D group. Figure two illustrates the
division of data through a scatter plot. Here you can visually see
evidence for heteroscedasticity in the data.
FIgure 2:

Labor and capital intensity deal with the amount of labor
and capital used in the research and development process.
Since financial statements do not reveal this information it is
impossible to retrieve these statistics.
All of these control statistics, with the exception of firm growth,
will be measured from 2005-2007 in order to stay in line with
the investment into research and development statistics. Firm
growth will be measured from 2004-2006 in order to account for
the growth of the firm in the year prior to the decision to invest
into research and development (Salamanca 2010).
IV. Results
The regression results for four models are presented in Table
2. The first model includes only the primary independent
variable, R&D / Revenue. Model two includes in the financial
controls which are firm growth, free cash flow, and external
financial dependence. The third regression includes all
variables. The fourth and final regression is a correction for
heteroscedasticity.
As shown in Table 2, there is not a lot of significance in
these regressions, which does not give much support
for the first hypothesis, which claims a direct relationship
between R&D expenditures and the changes in stock price.
However, a White’s test was ran which showed that there
was heteroscedasticity, which gives some support for the
second hypothesis. Heteroscedasticity explains that as the
independent variable changes, the standard deviation of the
dependent variable will change as well. In relation to this
paper, heteroscedasticity is showing that as investment into
R&D grows, the standard deviation of the rate of return of
stock prices is growing as well, which is showing that there
is a sense of risk in investing more funds into research and
development. In other words, heteroscedasticity is explaining
that by investing more into research and development the data
are experiencing more volatile returns in their stock price. By
using descriptive statistics more evidence can be shown for the
second hypothesis.
The scatter plot in Figure 2 shows all of the data with relation
to their investment into R&D and their rate of return on their
stock price over the recession period. In order to perform a
descriptive statistical analysis the data will be split into two.
The division of the data is shown in the scatter plot by a vertical
line. The descriptive statistics will analyze the two hypotheses

Table 3 shows the firms who have a smaller investment into
research and development listed on the left in blue, and the
firms who have invested more into research and development
listed on the right. The key figures to focus on here are the
mean and standard deviation of the two groups. As expected,
the mean rate of return on stock price for the higher invested
into R&D firms is higher than the lower invested R&D firms,
which shows evidence for the first hypothesis. Also, the
standard deviation is higher for the higher invested R&D firms
than the lower invested R&D firms, which shows evidence for
the second hypothesis. By using descriptive analysis, this paper
will test if the means and standard deviations for the two groups
are statistically different.
The two sample test of means with σ unknown and unequal
failed to reject the null hypothesis; therefore we cannot say
that the means for the two groups is statistically different in
this analysis. Therefore, due to the regression analysis and
the descriptive statistics failing to show support for the first
hypothesis we must reject it, and we cannot say that as firms
invest more funds into research and development they will
experience a higher rate of return on their stock price. These
results do not coincide with this paper’s theory which was
developed through past research done in Kafouros (2005). The
theory was that as production improved so would profitability.
These results are troublesome. However, with future research
and adjustments to this analysis, hopefully future results will be
more significant. The results for the two sample test of means
with σ unknown and unequal are shown in Table 4.
The difference in standard deviations test rejected the null
hypothesis. Therefore, we can say that there is a significant
difference in standard deviations for this analysis, and we can
accept hypothesis 2, which states that as more funds are spent
on research and development a firm’s profitability will become
more volatile causing a firm’s rate of return on their stock price
to fluctuate more over time. These results do coincide with
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theory stated in Machina (2008). Risk, therefore, does play its
role in expenditure on research and development. The analysis
for a difference in standard deviations can be shown in Table 5.
More analysis was done on these two groups to understand
why some companies spend more on research and
development and others spent less. This paper analyzed
the differences in the two groups by looking at their control
variables, which included firm size, firm growth, free cash flow,
market share and external financial dependence. Another
variable was included in this analysis, which was the beta
coefficient. The beta coefficient is a measure of a firm’s stock
price volatility.
As shown the firms who spent more on research and
development typically have fewer employees, a higher growth
rate, less free cash flow, a lower market share, and less
external financial dependence. In other words, those who
spend more on research and development tend to be smaller
and more growth driven. Those who spent less on research
and development tend to be more well established and more
risk adverse. Those larger, more risk adverse firms who spend
less on research and development also tend to have a more
stable stock price, which is supported by the beta coefficient.
This conclusion is also supported by the results found in the
regression analysis as well as the descriptive statistics for the
difference in the standard deviation for each group.
V. Conclusion
This paper has shown that as research and development
increases for a firm, their rate of return on their stock price
does not necessary increase more relative to other firms.
However, this paper has shown that those who spend more on
research and development do experience more volatile returns.
Therefore, the first hypothesis is rejected and the second
hypothesis is not rejected in the context of this paper. In relation
to other findings, Kafouros’s (2005) findings that a higher
investment into research and development will generate greater
productivity is neither supported nor rejected by the findings
presented here due to the differences in foci in the two papers.
The focus of Kafouros (2005) was productivity, and the focus
in this paper was profitability. Schumpeterian theory and the
Cobb-Douglass production are neither supported nor rejected
for the same purposes. However, Machine and Rothschild
(2008) are supported by the findings of this paper, which show
that more investment into research and development lead to a
greater deal of risk.
In order to improve the analysis, future research could evaluate
the problem addressed in this paper differently. Future
research could involve a larger database, a different sector
of the economy, or even use a different time period. By using
a larger database outliers’ effect on the database could be
weakened. Also with more data the strength of the regression
analysis would grow. In order to get a larger database future
research could either analyze a different sector of the economy,
or it could include more data in this sector of the economy.
For example, the data in this database came strictly from the
musculoskeletal medical device sector; however the database
could expand itself to include other medical device makers
outside of the musculoskeletal sector. Finally, future research
could examine a difference time period. Seeing that the time

period used was during a recession, there could have been
more extreme volatility than we would typically expect. Also
during a recession most companies are acquiring negative
returns and the firms are doing damage control. However, it
would be interesting to see an analysis of an expansionary
period where innovation is encouraged more.
So, what do the results mean? Should companies spend more
or less on research and development? The paper has given
us the answer that it depends. If a company is smaller and
more growth oriented, it could be beneficial to take the risk for
higher returns, however if a company is more well established
and is in a good position with more market share, it could be
more beneficial to spend less of their revenue on research and
development.
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Table 1: Variable Definitions and Expected Signs
Definition

Variable

Expected sign

Dependent Variable:
Profitability

Change in stock price over the recession
(Dec, 1 2007 – Jun, 1 2009)

Explanatory variables:
Main Focus
R&D / Revenue

Amount in dollars spent in R&D / Revenue

+

Growth

Change in revenue over the time period 2004-2006

+

Free Cash Flow

Leveraged free cash flow as stated in financial
statements

-

Market Share

Revenue of individual firm over total

+

Size

Number of Employees

+

External Financial Dependence

External financials as stated in financial statements

-

Labor Intensity

Labor used in research and development

-

Capital Intensity

Capital used in research and development

-

Control Variables

	
  
Variables
Constant
R&D / Revenue
Firm Growth
Free Cash Flow
EFD
Market Share
Firm Size
R^2

N

Table 2: R&D regression for Medical device Firms
Model 1
Model 2
Model 3
-.474**
-.489**
-.382
(-4.198)
(-3.225)
(-1.501)
1.360
1.452
.502
(1.110)
(.772)
(.191)
-3.17E-5
.001
(-.016)
(.323)
-9.37E-12
2.43E-10
(-.053)
(.230)
-1.47E-10
-1.92E-10
(.284)
(-.207)
.021
(.313)
-6.37E-5
(-.597)
.015
-.244
-.460
16

	
  
Reject
Null Hypothesis if t-stat > 1.753 (.05)

16

16

Sig level at .05* .01**
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Model 4
-.578**
(-3.981)
3.146
(1.303)
-.001
(-.479)
9.407E-11
(.000)
3.570E-10
(.000)
-.010
(-.234)
9.625E-6
(.167)
-.210
16

Table 3: Two Group Data Set with Mean and Standard Deviation Analysis
Low R&D
expenditure

Investment into
R&D

Rate of Return

High R&D
expenditure

Investment into
R&D

Rate of Return

SNN

4.4%

-34%

ANIK

14.53

-65%

SYK

6.25%

-45%

EXAC

6.36

-14%

ZMH

5.12%

-29%

NUVA

20.67

-11%

IART

5.48%

-36%

OFIX

8.00

-55%

RTIX

2.14%

-54%

VITA

15.82

8%

OSTE

5.23%

-51%

WMGI

7.30

-41%

CNMD

4.42%

-33%

ARTC

9.82

-80%

KCI

2.81%

-53%

SYNO

6.84

4%

Mean

4.48

-42%

Mean

11.17

-32%

σ

1.38

10

σ

5.23

33

	
  

Table 4: Two Sample Test of Means Population Unknown and Unequal

Table 5: Difference in Standard Deviations

H0 : μROR1 = μROR2

H0 : σROR1 = σROR2

Ha : μROR1 ≠ μROR2

Ha : σROR1 ≠ σROR2

tc = (Ẋ1 - Ẋ2) / (Sx1 – x2)

Fc = S

Degrees of freedom = 8.27

Degrees of Freedom = 7,7

Reject if t > 1.86

Reject H0 if Fc > 3.787

tc = .82

Fc = 10.82

We do not reject the null hypothesis

We reject the null hypothesis

2

	
  

1

2

/S

2

	
  
Table 6: Analysis of Low R&D Expenditure Group and High R&D Expenditure Group
Firm size

Firm growth

Free cash flow

Market share

External financial
dependence

Beta Coefficient

Low average

6,353

25%

$441,000,000

12%

$112,000,000

.98

High average

743

40%

$4,710,000

0.90%

$31,890,000

1.09
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